The NHS Is Set To Roll Out A Breakthrough Cholesterol-Lowering Medicine That Has The Potential To Save 30,000 Lives
It has been reported that hundreds of thousands of individuals will soon have access to a cholesterol-lowering medicine that could save 30,000 lives over the next decade.
Over the next three years, the NHS will make the medication available to 300,000 individuals with high cholesterol and a history of cardiovascular disease.
According to executives, the number of patients who will benefit from the new treatment, inclisiran, might reach over half a million after that initial year.
The medicine, which potentially save 55,000 heart attacks and strokes, is given twice a year as an injection and can be combined with other treatments such as statins.
Heart disease is the world's leading cause of mortality, accounting for a quarter of all deaths in England each year, taking the lives of approximately 140,000 people.
More over 40% of adults in the United States have excessive cholesterol, putting them at a greater risk of developing heart disease.
Approximately 6.5 million persons in England are now taking antidepressant medications.